tolbutamide has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Ashford, ML; Harvey, J | 1 |
Alber, J; Ashcroft, FM; Balthasar, N; Belgardt, BF; Brüning, JC; Burdakov, D; Coppari, R; Fekete, C; Hampel, B; Horvath, TL; Janoschek, R; Koch, L; Krone, W; Ma, X; Mak, TW; Münzberg, H; Plum, L; Rother, E; Schwenk, F; Seibler, J; Shanabrough, M; Suzuki, A | 1 |
3 other study(ies) available for tolbutamide and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Insulin occludes leptin activation of ATP-sensitive K+ channels in rat CRI-G1 insulin secreting cells.
Topics: Adenosine Triphosphate; Androstadienes; Animals; Binding, Competitive; Chromones; Diabetes Mellitus, Type 2; Diazoxide; Drug Interactions; Electric Conductivity; Enzyme Inhibitors; Hypoglycemic Agents; Insulin; Insulin Antagonists; Insulin Secretion; Insulin-Like Growth Factor I; Ion Channel Gating; Leptin; Membrane Potentials; Morpholines; Patch-Clamp Techniques; Potassium Channels; Proteins; Rats; Tolbutamide; Vasodilator Agents; Wortmannin | 1998 |
Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity.
Topics: Animals; Chromones; Diet; Eating; Female; Hypoglycemic Agents; Hypothalamus; Insulin; Leptin; Male; Membrane Potentials; Mice; Mice, Knockout; Morpholines; Neurons; Obesity; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Phosphoinositide-3 Kinase Inhibitors; Potassium Channels; Pro-Opiomelanocortin; PTEN Phosphohydrolase; Second Messenger Systems; Tolbutamide | 2006 |